US Patent 7915293 Ubiquitin ligase inhibitors
Patent 7915293 was granted and assigned to Rigel Pharmaceuticals on March, 2011 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7915293 Ubiquitin ligase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.